2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theOsteoporosis Treatment Market from 2025 to 2034?

The surge in prevalence and occurrence of osteoporosis is anticipated to drive the expansion of the market for osteoporosis treatment. Osteoporosis, a disease of the bone, develops when there is a transformation in bone strength and composition or a decline in bone mass and mineral density. Majority of osteoporosis medications work by reducing the deterioration rate of the bones. In addition, hormone-based treatments such as estrogen can aid in sustaining bone density, particularly when administered immediately post-menopause. For example, Amgen, a US-based biopharmaceutical company, stated in May 2022 that the yearly tally of fractures caused by osteoporosis is projected to surge by 68% to 3.2 million by 2040. Also, the National Library of Medicine, a US national resource for health practitioners, declared in April 2022 that about 549,000 new fragility fractures are recorded each year in the UK, with men accounting for a third of these cases. Due to an aging population, this number is expected to witness a 19.6% growth by 2030. Consequently, the escalating prevalence and incidence of osteoporosis is fuelling the osteoporosis treatment market’s expansion.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

How Will the Growth Rate of the Osteoporosis Treatment Market Impact Industry Trends by 2034?

There has been a consistent increase in the size of the osteoporosis treatment market over the past few years. The market is expected to expand from $13.96 billion in 2024 to $14.62 billion in 2025, representing a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this growth during the historic period include an older population demographic, the use of hormone replacement therapies, the supplementation of calcium and vitamin D, the advent of superior diagnostic tools, and the incorporation of digital health solutions.

The market for osteoporosis treatment is predicted to experience robust expansion in the upcoming years, reaching a market value of $17.84 billion by 2029 with a compound annual growth rate (CAGR) of 5.1%. The surge expected during the forecast period may be due to a rise in inactive lifestyle, an increase in the occurrence of secondary osteoporosis, the advent of virtual bone fracture clinics, development in gene therapy for osteoporosis, and heightened attention towards men’s bone health. Noteworthy trends to watch for during this period encompass progress in biologics, the application of artificial intelligence and blockchain to bone health records, and the incorporation of machine learning techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

How Are Market Trends and Innovations Revolutionizing theOsteoporosis Treatment Industry in Recent Times?

Prominent businesses in the osteoporosis treatment landscape are concentrating on the creation of cutting-edge injectable osteoporosis therapies to maintain their market presence. Injectable osteoporosis therapies are drugs administered through injection to prevent bone deterioration and reduce the risk of fractures in those with osteoporosis. These treatments provide a direct approach to improving bone mass and fortifying skeletal health. For instance, Apotex Corp., a pharmaceutical firm based in Canada, rolled out the Teriparatide Injection in November 2023. It is a pre-filled pen designed for single-patient use for osteoporosis treatment. It boasts a concentration of 250 mcg/mL and provides 28 daily doses of 20 mcg each per pen. This innovative product aims to increase access to affordable treatments for approximately 10 million Americans diagnosed with osteoporosis. This development highlights Apotex’s commitment to manufacturing intricate generic medications, ensuring that patients are able to access premium quality treatments.

Which Key Market Players Are Shaping the Future and Growth of theOsteoporosis Treatment Market?

Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy’s Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The osteoporosis treatment market covered in this report is segmented –

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor

2) By Route Of Administration: Oral, Injectable, Other Routes

3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations

3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)

4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene

5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues

6) By Rank Ligand (RANKL) Inhibito: Denosumab

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp

What Regions Are Dominating the Osteoporosis Treatment Market Growth?

North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Osteoporosis Treatment Maret 2025, By The Business Research Company:

Refrigerated Goods Trucking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerated-goods-trucking-global-market-report

Warehouse Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/warehouse-automation-global-market-report

Autonomous Last Mile Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autonomous-last-mile-delivery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: